Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Urologic Device Innovation and Trends: An Analysis of Food and Drug Administration Approvals From 1990 to 2023.

PMID: 41886403 ·

Sam Duggan, Antony Fuleihan, Arjun K Menta, Marco Goldberg, Costas Lallas, Mihir Shah, Patrick Shenot, Adam Metwalli, Scott Hubosky, Patrick Gomella, Whitney Smith, Masaya Jimbo, Paul Chung, Paul Bloch, Leonard Gomella

JournalUrology practice
Year
PMID41886403

Abstract

Urology has historically led surgical innovation with the early adoption of endoscopy, minimally invasive surgery, and neurostimulation devices. However, the current trajectory of innovation across urologic subspecialties remains undefined. Our objective was to characterize trends in US Food and Drug Administration device approvals in urology from 1990 to 2023 and assess regulatory, market, and subspecialty factors associated with device development activity. US Food and Drug Administration data

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.

↑